Ithurts
FDA Label NDC 63776-270

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Viatrexx Bio Incorporated for the product Ithurts (NDC 63776-270). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, uses, warnings, directions, other ingredients, other information, principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Anti-interleukin-1 200K, Apomorphine 200K, Beta Endorphin 200K

Purpose

Anti-Interleukin-1Anti-inflammation
ApomorphinePain relief
Beta endorphinPain relief

Uses

To help with inflammatory & pain symptoms

Warnings

Stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. If pregnant or breastfeeding, ask a health care practitioner before use.

Directions

1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.

Other Ingredients

Alcohol and Water

Other Information

Normal storage use.

Do not use if tamper-evident seal is broken or removed.

Principal Display Panel

ITEM: VPC0290

NDC 63776-270-14

Homeopathic remedy

Ithurts

• To help with inflammatory & pain symptoms

Oral spray
30ml 1 oz

Viatrexx™ Bio Incorporated

Manufactured by Viatrexx
www.viatrexx.com
Newark, DE 19713

Ithurts Box (Ithurtsbox)

Ithurts Box (Ithurtsbox)

Ithurts

30 mL
1 oz

Viatrexx™ Bio Incorporated

ITEM: VPC0290
NDC: 63776-270-14

INDICATIONS:
To help with inflammatory & pain symptoms

DIRECTIONS:
1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.

Mfg. for
Viatrexx Bio Incorporated
www.viatrexx.com
Newark, DE 19713

Ingredients (Ithurtsingr)

Ingredients (Ithurtsingr)

* Please review the disclaimer below.